Brand Description
EMRELIS is a targeted therapy for treating advanced non-squamous non-small cell lung cancer (NSCLC) with high c-Met protein overexpression, approved under accelerated conditions based on its efficacy and safety profile.
Associated Domains
IAB Categories:
Health & FitnessScience
IAB Ad Products:
Medical and BiotechnologyHealth and Medical Services
| ID | Domain | Seat | Bid | Timestamp | Status | Ad Format | Sub Format | Size | Quality Score | Data Transferred | Computational Cost |
|---|